Obermatt
See Similar Stocks →

Sionna Therapeutics

NMQ:SION · US8294011080
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings83
Price/Book13
Dividend Yield—
Revenue Growth—
Profit Growth59
Capital Growth51
TSR 52w74
Leverage54
Liquidity28
Refinancing89
Combined—
Analyst Opinions13
Pro Holdings35
Opinion Changes79
Market Pulse9

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded2019
Employees66
Websitesionnatx.com
ISINUS8294011080
Last UpdateApr 2, 2026
Index & Theme
Chronic DiseasesGenetic DisorderRespiratoryGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Description

Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company is advancing a pipeline of small molecules engineered to correct the defects caused by the F508del genetic mutation, the most common CFTR mutation, which o…

Similar Stocks

The companies this stock is ranked against.

Compare Sionna Therapeutics with its peers
Dianthus Therapeutics
NAQ:DNTH
20
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Metagenomi Therapeutics
NSQ:MGX
24
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
MeiraGTx
NSQ:MGTX
18
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Kymera Therapeutics
NMQ:KYMR
30
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Shattuck Labs
NSQ:STTK
50
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Disc Medicine
NMQ:IRON
5
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →